Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF Mutations in CNS Tumors-Prognostic Markers and Therapeutic Targets.

CNS drugs - 1 Jul 2023

Muniz Thiago P, Mason Warren P

Abstract excerpt

Gliomas are a heterogeneous group of brain tumors with limited therapeutic options. However, identification of BRAF V600E mutations in a subset of gliomas has provided a genomic-targeted approach for management of these diseases. In this review, we aimed to review the role of BRAF V600E in gliomagenesis, to characterize concurrent genomic alterations and their potential prognostic implications, and to review...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Central Nervous System Neoplasms
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 37268805
DOI: 10.1007/s40263-023-01016-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF Mutations in CNS Tumors-Prognostic Markers and Therapeutic Targets.PMID 37268805Read ↗

Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic ImplicationsSemantic proximity Read ↗

Integrated molecular and clinical analysis of BRAF-mutant glioma in adultsSemantic proximity Read ↗

Molecular biology of high-grade gliomas: what should the clinician know?Semantic proximity Read ↗

Targeted Therapy for BRAF Mutant Brain Tumors.Semantic proximity Read ↗

Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma.Semantic proximity Read ↗

The Role of Molecular Diagnostics in the Management of Patients with Gliomas.Semantic proximity Read ↗

Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.Semantic proximity Read ↗

Prognostic Role of BRAF Mutation in Low-Grade Gliomas: Meta-analysis.Semantic proximity Read ↗

Treatment of Adult Lower-Grade Glioma in the Era of Genomic Medicine.Semantic proximity Read ↗

Advances in the molecular genetics of gliomas — implications for classification and therapySemantic proximity Read ↗

Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm.Semantic proximity Read ↗

A comprehensive overview on the molecular biology of human glioma: what the clinician needs to knowSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.